Cargando…

A consensus prognostic gene expression classifier for ER positive breast cancer

BACKGROUND: A consensus prognostic gene expression classifier is still elusive in heterogeneous diseases such as breast cancer. RESULTS: Here we perform a combined analysis of three major breast cancer microarray data sets to hone in on a universally valid prognostic molecular classifier in estrogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teschendorff, Andrew E, Naderi, Ali, Barbosa-Morais, Nuno L, Pinder, Sarah E, Ellis, Ian O, Aparicio, Sam, Brenton, James D, Caldas, Carlos
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794561/ https://www.ncbi.nlm.nih.gov/pubmed/17076897 http://dx.doi.org/10.1186/gb-2006-7-10-r101

Ejemplares similares

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2008)

Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling
por: Naderi, Ali, et al.
Publicado: (2004)

High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
por: Chin, Suet F, et al.
Publicado: (2007)

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2007)

Prognostic gene network modules in breast cancer hold promise
por: Teschendorff, Andrew E, et al.
Publicado: (2010)

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2015)

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2016)

The breast cancer somatic 'muta-ome': tackling the complexity
por: Teschendorff, Andrew E, et al.
Publicado: (2009)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

Molecular profiling of breast cancer: portraits but not physiognomy
por: Brenton, James D, et al.
Publicado: (2001)

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
por: Blenkiron, Cherie, et al.
Publicado: (2007)

The prognostic effects of somatic mutations in ER-positive breast cancer
por: Griffith, Obi L., et al.
Publicado: (2018)

Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
por: Teschendorff, Andrew E, et al.
Publicado: (2010)

Dynamics of breast cancer relapse reveal late recurring ER-positive genomic subgroups
por: Rueda, Oscar M., et al.
Publicado: (2019)

Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer
por: Griffith, Obi L., et al.
Publicado: (2018)

2019 ERS cough guideline: consensus and controversy
por: Chen, Ruchong, et al.
Publicado: (2020)

Intra-Tumour Signalling Entropy Determines Clinical Outcome in Breast and Lung Cancer
por: Banerji, Christopher R. S., et al.
Publicado: (2015)

Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
por: Joseph, Chitra, et al.
Publicado: (2019)

Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2015)

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
por: Kurozumi, Sasagu, et al.
Publicado: (2017)

Elucidating the Altered Transcriptional Programs in Breast Cancer using Independent Component Analysis
por: Teschendorff, Andrew E, et al.
Publicado: (2007)

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
por: Batra, Atul, et al.
Publicado: (2020)

Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER–Golgi intermediate compartment
por: Sirkis, Daniel W., et al.
Publicado: (2017)

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
por: Zabeck, Heike, et al.
Publicado: (2018)

Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
por: Kim, Tae-Jung, et al.
Publicado: (2012)

PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations
por: Bendl, Jaroslav, et al.
Publicado: (2014)

Classifying the unclassifiable—a Delphi study to reach consensus on the fibrotic nature of diseases
por: Massen, G M, et al.
Publicado: (2023)

A simple and reproducible prognostic index in luminal ER-positive breast cancers
por: Castellano, I., et al.
Publicado: (2013)

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
por: Zhou, Meng, et al.
Publicado: (2023)

Invited commentary—WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both?
por: Uttley, Lesley, et al.
Publicado: (2020)

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2‐positive and ER‐positive breast cancer patients: an explorative analysis from the NeoSphere trial
por: Triulzi, Tiziana, et al.
Publicado: (2021)

The multigene classifiers 95GC/42GC/155GC for precision medicine in ER‐positive HER2‐negative early breast cancer
por: Naoi, Yasuto, et al.
Publicado: (2021)

Correction to: Classifying the unclassifiable—a Delphi study to reach consensus on the fibrotic nature of diseases
Publicado: (2023)

Bioinformatics Analysis of the Prognostic Significance of CAND1 in ERα-Positive Breast Cancer
por: Alhammad, Rashed
Publicado: (2022)

Prognostic significance of Ki67 in Chinese women diagnosed with ER(+)/HER2(−) breast cancers by the 2015 St. Gallen consensus classification
por: Hu, Yue, et al.
Publicado: (2017)

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
por: Wrzesiński, Tomasz, et al.
Publicado: (2015)

Cervical Cancer Prediction by Merging Features of Different Colposcopic Images and Using Ensemble Classifier
por: Nikookar, Elham, et al.
Publicado: (2021)

Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer
por: Alhammad, Rashed
Publicado: (2022)

Reply to Letter to Editor: “HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?”
por: Li, Shuai, et al.
Publicado: (2020)

Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas
por: Bièche, I, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_pikb3ru3l5e84b8cndbb10tbl5